Evidence map›Paper›PMID 11152524›Full record

ArticleJournal of virology2001

Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr.

M P Sherman, C M de Noronha, M I Heusch, S Greene, W C Greene

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 121 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. HIV-1 Vpr-a still "enigmatic multitasker".Frontiers in microbiology · 2014
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

M P ShermanGladstone Institute of Virology and Immunology, University of California, San Francisco, California 94141-9100, USA.
C M de Noronha
M I Heusch
S Greene
W C Greene
Institute of Virology of the Slovak Academy of Sciences · SKPalmetto Hematology Oncology · US

Funding

UCSF-GIVI CENTER FOR AIDS RESEARCHP30MH059037 · NIMH · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI VOLBERDING, PAUL A · 1998 to 2001
$4.9M
NIMH NIH HHS P30 MH59037
6 · The paper itself

Abstract

Human immunodeficiency virus type 1 (HIV-1) is capable of infecting nondividing cells such as macrophages because the viral preintegration complex is able to actively traverse the limiting nuclear pore due to the redundant and possibly overlapping nuclear import signals present in Vpr, matrix, and integrase. We have previously recognized the presence of at least two distinct and novel nuclear import signals residing within Vpr that, unlike matrix and integrase, bypass the classical importin alpha/beta-dependent signals and do not require energy or a RanGTP gradient. We now report that the carboxy-terminal region of Vpr (amino acids 73 to 96) contains a bipartite nuclear localization signal (NLS) composed of multiple arginine residues. Surprisingly, when the leucine-rich Vpr(1-71) fragment, previously shown to harbor an NLS, or full-length Vpr is fused to the C terminus of a green fluorescent protein-pyruvate kinase (GFP-PK) chimera, the resultant protein is almost exclusively detected in the cytoplasm. However, the addition of leptomycin B (LMB), a potent inhibitor of CRM1-dependent nuclear export, produces a shift from a cytoplasmic localization to a nuclear pattern, suggesting that these Vpr fusion proteins shuttle into and out of the nucleus. Studies of nuclear import with GFP-PK-Vpr fusion proteins in the presence of LMB reveals that both of the leucine-rich alpha-helices are required for effective nuclear uptake and thus define a unique NLS. Using a modified heterokaryon analysis, we have localized the Vpr nuclear export signal to the second leucine-rich helix, overlapping a portion of the amino-terminal nuclear import signal. These studies thus define HIV-1 Vpr as a nucleocytoplasmic shuttling protein.

Indexed as

KaryopherinsReceptors, Cytoplasmic and NuclearAmino Acid SequenceCarrier ProteinsCell NucleusCytoplasmExportin 1 ProteinFatty Acids, UnsaturatedGene Products, vprHeLa CellsHIV-1HumansMolecular Sequence DataProtein Structure, Secondaryvpr Gene Products, Human Immunodeficiency VirusCarrier ProteinsExportin 1 ProteinFatty Acids, UnsaturatedGene Products, vprKaryopherinsleptomycin BReceptors, Cytoplasmic and Nuclearvpr Gene Products, Human Immunodeficiency Virus

Identifiers

PMID11152524
PMCPMC114057
OpenAlexW2024569169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.